Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

International Clinical Psychopharmacology

Volumn 23, Issue 2, 2008, Pages 84-87

  Williams, Lana J ^a   Henry, Margaret J ^a   Berk, Michael ^a   Dodd, Seetal ^a   Jacka, Felice N ^a   Kotowicz, Mark A ^a   Nicholson, Geoffrey C ^a   Pasco, Julie A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone mineral density; Depression; Selective serotonin reuptake inhibitors

Indexed keywords

SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BONE DENSITY; BONE METABOLISM; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; LIFESTYLE; LONG TERM CARE; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROTONINERGIC SYSTEM; STATISTICAL ANALYSIS; TREATMENT DURATION; WOMEN'S HEALTH;

ADULT; AGED; BONE DENSITY; DEPRESSIVE DISORDER; EXERCISE; FEMALE; HEALTH STATUS; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 39849100862     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3282f2b3bb     Document Type: Article

References (30)

1. Baecke JA, Burema J, Frijters JE (1982). A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936-942.
2. Battaglino R, Fu J, Spate U, Ersoy U, Joe M, Sedaghat L, et al. (2004). Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19:1420-1431.
3. Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A (1997). Acute phase proteins in major depression. J Psychosom Res 43:529-534.
4. Bliziotes MM, Eshleman AJ, Zhang XW, Wiren KM (2001). Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 29:477-486.
5. Cauley JA, Fullman RL, Stone KL, Zmuda JM, Bauer DC, Barrett-Connor E, et al. (2005). Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 16:1525-1537.
6. Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, et al. (2007). Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167:1240-1245.
7. Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, et al. (2003). Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163:949-957.
8. Giles C, Ireland P (1996). Dietary Questionnaire for Epidemiological Studies (Version 2). Melbourne: The Cancer Council Victoria.
9. Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, et al. (2006). Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98:139-151.
10. Gustafsson BI, Waarsing E, Stunes K, Thommesen L, Waldum H, van Leeuwen H, et al. (2005). Anti-depressants, depressing effects on bone? J Bone Miner Res 20:S113.
11. Gustafsson BI, Westbroek I, Waarsing JH, Waldum H, Solligard E, Brunsvik A, et al. (2006). Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats. J Cell Biochem 97:1283-1291.
12. Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E, et al. (2007). Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167:1246-1251.
13. Henry MJ, Pasco JA, Nicholson GC, Seeman E, Kotowicz MA (2000). Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 3:261-268.
14. Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A (2003). Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158:77-84.
15. Jacka FN, Pasco JA, Henry MJ, Kotowicz MA, Dodd S, Nicholson GC, et al. (2005). Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study. Menopause 12:88-91.
16. Jacka FN, Pasco JA, Henry MJ, Korn S, Williams LJ, Kotowicz MA, et al. (2007). Depression and bone mineral density in a community sample of men: Geelong Osteoporosis Study. JMHG 4:292-297.
17. Kinjo M, Setoguchi A, Schneeweiss S, Solomon D (2005). Bone mineral density in subjects using central nervous system-active medication. Am J Med 118:1414-1419.
18. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998). Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303-1307.
19. Marshall D, Johnell O, Wedel H (1996). Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254-1259.
20. Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, et al. (1996). Bone mineral density in women with depression. N Engl J Med 335:1176-1181.
21. Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M (2007). Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study. J Affect Disorders (in press).
22. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, et al. (2007). Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188-194.
23. Sogaard AJ, Joakimsen RM, Tverdal A, Fonnebo V, Magnus JH, Berntsen GK (2005). Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromso Study. Osteoporos Int 16:887-897.
24. Vaswani M, Linda FK, Ramesh S (2003). Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27:85-102.
25. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA (1991). A physical activity questionnaire for the elderly. Med Sci Sports Exerc 23:974-979.
26. Warden SJ, Bliziotes MM, Wiren KM, Eshleman AJ, Turner CH (2005). Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Mol Cell Endocrinol 242:1-9.
27. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH (2005). Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146:685-693.
28. Westbroek I, van der Plas A, de Rooij KE, Klein-Nulend J, Nijweide PJ (2001). Expression of serotonin receptors in bone. J Biol Chem 276:28961-28968.
29. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS (1999). Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:484-490.
30. Yazici KM, Akinci A, Sutcu A, Ozcakar L (2003). Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 117:271-275.